USD 57.38
(-4.95%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.55 Billion USD | 4.41% |
2022 | 2.44 Billion USD | 3.58% |
2021 | 2.36 Billion USD | 61.35% |
2020 | 1.46 Billion USD | 54.73% |
2019 | 946.3 Million USD | 37.38% |
2018 | 688.82 Million USD | 16035.44% |
2017 | 4.26 Million USD | -7.86% |
2016 | 4.63 Million USD | -4.51% |
2015 | 4.85 Million USD | 385.2% |
2014 | 1 Million USD | -26.47% |
2013 | 1.36 Million USD | -20.51% |
2012 | 1.71 Million USD | 71.1% |
2011 | 1 Million USD | 0.0% |
2010 | 1 Million USD | 0.0% |
2009 | 1 Million USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 2.55 Billion USD | 0.02% |
2024 Q3 | 2.75 Billion USD | -0.92% |
2024 Q2 | 2.78 Billion USD | 8.95% |
2023 Q2 | 2.48 Billion USD | -2.16% |
2023 FY | 2.55 Billion USD | 4.41% |
2023 Q4 | 2.55 Billion USD | 2.96% |
2023 Q3 | 2.48 Billion USD | 0.05% |
2023 Q1 | 2.53 Billion USD | 3.6% |
2022 Q3 | 2.44 Billion USD | 0.01% |
2022 Q1 | 2.38 Billion USD | 0.83% |
2022 Q4 | 2.44 Billion USD | 0.02% |
2022 FY | 2.44 Billion USD | 3.58% |
2022 Q2 | 2.44 Billion USD | 2.69% |
2021 Q2 | 2.38 Billion USD | 0.4% |
2021 Q4 | 2.36 Billion USD | -0.89% |
2021 FY | 2.36 Billion USD | 61.35% |
2021 Q3 | 2.38 Billion USD | 0.1% |
2021 Q1 | 2.37 Billion USD | 61.99% |
2020 FY | 1.46 Billion USD | 54.73% |
2020 Q1 | 1.66 Billion USD | 76.04% |
2020 Q2 | 1.68 Billion USD | 1.09% |
2020 Q3 | 1.71 Billion USD | 1.77% |
2020 Q4 | 1.46 Billion USD | -14.56% |
2019 Q3 | 817.02 Million USD | 65.38% |
2019 Q2 | 494.02 Million USD | -37.88% |
2019 FY | 946.3 Million USD | 37.38% |
2019 Q4 | 946.3 Million USD | 15.82% |
2019 Q1 | 795.29 Million USD | 15.46% |
2018 Q2 | 653.38 Million USD | 33.09% |
2018 Q3 | 673.42 Million USD | 3.07% |
2018 FY | 688.82 Million USD | 16035.44% |
2018 Q1 | 490.92 Million USD | 11399.77% |
2018 Q4 | 688.82 Million USD | 2.29% |
2017 Q3 | 4.69 Million USD | -0.82% |
2017 Q2 | 4.73 Million USD | -0.8% |
2017 Q1 | 4.76 Million USD | 2.91% |
2017 FY | 4.26 Million USD | -7.86% |
2017 Q4 | 4.26 Million USD | -9.0% |
2016 Q3 | 4.84 Million USD | -0.76% |
2016 Q1 | 4.91 Million USD | 1.38% |
2016 FY | 4.63 Million USD | -4.51% |
2016 Q4 | 4.63 Million USD | -4.38% |
2016 Q2 | 4.88 Million USD | -0.75% |
2015 Q3 | 3.53 Million USD | 1.35% |
2015 FY | 4.85 Million USD | 385.2% |
2015 Q4 | 4.85 Million USD | 37.26% |
2015 Q2 | 3.48 Million USD | 174.86% |
2015 Q1 | 1.26 Million USD | 26.9% |
2014 Q1 | 1.26 Million USD | -6.69% |
2014 FY | 1 Million USD | -26.47% |
2014 Q4 | 1 Million USD | 0.0% |
2014 Q3 | 1 Million USD | -15.04% |
2014 Q2 | 1.17 Million USD | -7.25% |
2013 Q1 | 1.62 Million USD | -5.03% |
2013 Q3 | 1.44 Million USD | -5.79% |
2013 Q4 | 1.36 Million USD | -6.14% |
2013 FY | 1.36 Million USD | -20.51% |
2013 Q2 | 1.53 Million USD | -5.35% |
2012 Q4 | 1.71 Million USD | -4.73% |
2012 FY | 1.71 Million USD | 71.1% |
2012 Q1 | 1 Million USD | 0.0% |
2012 Q2 | 1 Million USD | 0.0% |
2012 Q3 | 1.79 Million USD | 79.6% |
2011 Q2 | 1 Million USD | 0.0% |
2011 Q3 | 1 Million USD | 0.0% |
2011 Q4 | 1 Million USD | 0.0% |
2011 FY | 1 Million USD | 0.0% |
2011 Q1 | 1 Million USD | 0.0% |
2010 Q2 | 1 Million USD | 0.0% |
2010 Q4 | 1 Million USD | 0.0% |
2010 Q1 | 1 Million USD | 0.0% |
2010 FY | 1 Million USD | 0.0% |
2010 Q3 | 1 Million USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | 1 Million USD | 0.0% |
2009 FY | 1 Million USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bionano Genomics, Inc. | 87.94 Million USD | -2804.846% |
Prenetics Global Limited | 2.36 Million USD | -107722.146% |
Star Equity Holdings, Inc. | 3.6 Million USD | -70687.614% |
CareDx, Inc | 34.22 Million USD | -7365.372% |
Exagen Inc. | 23.72 Million USD | -10669.887% |
Inotiv, Inc. | 417.64 Million USD | -511.704% |
Guardant Health, Inc. | 1.35 Billion USD | -88.713% |
Biodesix, Inc. | 60.69 Million USD | -4109.397% |
BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1915057.989% |
Precipio, Inc. | 1.11 Million USD | -228818.011% |
iSpecimen Inc. | 196.24 Thousand USD | -1301710.501% |
Natera, Inc. | 441.99 Million USD | -478.001% |
Aspira Women's Health Inc. | 2.26 Million USD | -112641.615% |
Standard BioTools Inc. | 98.21 Million USD | -2501.288% |
23andMe Holding Co. | 76.51 Million USD | -3238.855% |
Castle Biosciences, Inc. | 15.31 Million USD | -16586.643% |
Personalis, Inc. | 48.96 Million USD | -5117.771% |
Aclaris Therapeutics, Inc. | 426 Thousand USD | -599600.704% |
Applied DNA Sciences, Inc. | 1.23 Million USD | -206299.06% |
OpGen, Inc. | 13.04 Million USD | -19485.883% |
T2 Biosystems, Inc. | 49.49 Million USD | -5061.269% |
Myriad Genetics, Inc. | 145 Million USD | -1661.879% |
ICON Public Limited Company | 3.93 Billion USD | 35.132% |
NeoGenomics, Inc. | 611.67 Million USD | -317.658% |
Star Equity Holdings, Inc. | 3.6 Million USD | -70687.614% |
IDEXX Laboratories, Inc. | 947.88 Million USD | -169.52% |
RadNet, Inc. | 1.49 Billion USD | -71.329% |
MDxHealth SA | 41.26 Million USD | -6091.021% |
Psychemedics Corporation | 2.29 Million USD | -111071.671% |
Illumina, Inc. | 2.26 Billion USD | -12.941% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 94.06 Million USD | -2615.799% |
DarioHealth Corp. | 29.54 Million USD | -8548.065% |
Fulgent Genetics, Inc. | 14.9 Million USD | -17037.754% |
Sera Prognostics, Inc. | 1.85 Million USD | -137398.654% |
ENDRA Life Sciences Inc. | 394.4 Thousand USD | -647644.819% |
OPKO Health, Inc. | 326.56 Million USD | -682.305% |
Medpace Holdings, Inc. | 142.12 Million USD | -1697.558% |
Neogen Corporation | 906.23 Million USD | -181.904% |
Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -293061.319% |
Prenetics Global Limited | 2.36 Million USD | -107722.146% |
Mainz Biomed B.V. | 7.42 Million USD | -34326.637% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -161730.856% |
Trinity Biotech plc | 67.42 Million USD | -3688.875% |
Neuronetics, Inc. | 62.47 Million USD | -3989.261% |
Sotera Health Company | 2.32 Billion USD | -9.784% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -161730.856% |